Healthcare Marketing Deals

Haleon Taps Collectively to Enhance its Influencer Marketing Strategies

Haleon, a consumer healthcare company based in the U.K., has announced that Collectively will take on the role of its primary influencer marketing partner for the U.S. market. With a duration of three years, this collaboration underscores Haleon's long-term vision for enhancing brand visibility and engagement in the competitive U.S. market.

The agency will play a pivotal role in orchestrating influencer-led initiatives tailored to Haleon's diverse portfolio of brands, including renowned products such as Advil painkiller, Sensodyne toothpaste, and Tums antacid tablets. These initiatives will tap a range of creators, including celebrities, nano-influencers, and healthcare professionals who have amassed significant social followings.

With a focus on leveraging influencers across various tiers and platforms, this partnership epitomizes Haleon's commitment to innovation and consumer engagement.

Image Credit: fizkes

Influencer-led Marketing
Opportunity to capitalize on diverse influencer tiers and platforms for enhanced consumer engagement.
Long-term Partnership Vision
Potential for sustained brand visibility and engagement through extended collaboration strategies.
Healthcare Brand Enhancement
Advancements in brand visibility and consumer engagement within the competitive U.S. market.

Who This Affects Most

Healthcare Marketing
Potential for disruptive innovation in leveraging influencers to promote healthcare products and brands.
Consumer Goods
Opportunity to enhance brand visibility and engagement through influencer-led marketing initiatives.
Advertising and PR
Utilizing long-term partnership vision to drive innovative influencer strategies in the competitive market landscape.
SCORE
1.7 out of 10
GENDER
50% Men50% Women
MARKETTop markets: North America
GENERATION
  • Gen Alpha
  • Gen Z (primary audience)
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 11%
Activity 17%
Freshness 24%